NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of data, technology and market infrastructure, today announced that it has launched two new thematic equity index futures contracts: the ICE Biotechnology Gross Total Return (GTR) Index and the ICE Semiconductor GTR Index futures contracts.
The ICE Biotechnology GTR Index futures contract is cash-settled with a notional value equal to $100 times the ICE Biotechnology Index closing gross total return index value (Index symbol: ICEBIOT). The ICE Semiconductor GTR Index futures contract is also cash-settled and has a notional value equal to $50 times the ICE Semiconductor Index closing gross total return index value (Index symbol: ICESEMIT). Both contracts trade on ICE Futures U.S. The ICE Futures U.S. contract symbols are IUT for the ICE Biotechnology GTR Index futures and IUS for the ICE Semiconductor GTR Index futures contracts.
Both the ICE Biotechnology Index and the ICE Semiconductor Index are rules-based, modified float-adjusted market capitalization-weighted indices that track the performance of qualifying U.S. listed biotechnology companies and the thirty largest U.S. listed semiconductor companies respectively. These indices comprise stocks listed on major U.S. exchanges and are constructed using sector and industry classifications from the ICE Uniform Sector Classification Schema.
“The last two years have seen the narratives around public health and supply chain dynamics reach new levels of prominence and significance in our daily lives,” said Caterina Caramaschi, Global Head of Equity Derivatives at ICE. “The new futures contracts based on the ICE Biotechnology Index and ICE Semiconductor Index are designed to offer investors tools to manage exposure to these megatrends as they become increasingly important to global economies.”
“ICE indices have helped market participants capture exposure to some of the most dynamic trends that are shaping the global economy,” said Amanda Hindlian, President of Fixed Income and Data Services at ICE. “The ICE Biotechnology Index and ICE Semiconductor Index provide market participants with effective tools to track advancements in areas like biotechnology and genomics, as well as supply and demand imbalances for semiconductors.”
In addition to these futures contracts, the indices serve as the benchmark for investment products. In June 2021, the iShares Biotechnology ETF (IBB) and the iShares Semiconductor ETF (SOXX) began tracking the ICE Biotechnology Index and the ICE Semiconductor Index, respectively. To learn more about ICE’s indices, please visit: https://www.theice.com/market-data/indices.
About Intercontinental Exchange
Intercontinental Exchange, Inc. (NYSE: ICE) is a Fortune 500 company that designs, builds and operates digital networks to connect people to opportunity. We provide financial technology and data services across major asset classes that offer our customers access to mission-critical workflow tools that increase transparency and operational efficiencies. We operate exchanges, including the New York Stock Exchange, and clearing houses that help people invest, raise capital and manage risk across multiple asset classes. Our comprehensive fixed income data services and execution capabilities provide information, analytics and platforms that help our customers capitalize on opportunities and operate more efficiently. At ICE Mortgage Technology, we are transforming and digitizing the U.S. residential mortgage process, from consumer engagement through loan registration. Together, we transform, streamline and automate industries to connect our customers to opportunity.
Trademarks of ICE and/or its affiliates include Intercontinental Exchange, ICE, ICE block design, NYSE and New York Stock Exchange. Information regarding additional trademarks and intellectual property rights of Intercontinental Exchange, Inc. and/or its affiliates is located here. Key Information Documents for certain products covered by the EU Packaged Retail and Insurance-based Investment Products Regulation can be accessed on the relevant exchange website under the heading “Key Information Documents (KIDS).”
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 — Statements in this press release regarding ICE’s business that are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE’s Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on February 3, 2022.
Source: Intercontinental Exchange
ICE-CORP
Contacts
ICE Media Contact
Rebecca Mitchell
+44 7951 057351
rebecca.mitchell@ice.com
ICE Investor Contact
Mary Caroline O’Neal
marycaroline.oneal@ice.com
(770) 738-2151